RXSIGHT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against RxSight, Inc. and Encourages Investors to Contact the Firm

Core Viewpoint - A class action lawsuit has been filed against RxSight, Inc. for allegedly making false statements and failing to disclose significant issues affecting its sales and financial guidance during the specified class period [1][2][3]. Summary by Sections Class Action Lawsuit - The lawsuit is on behalf of all individuals and entities who purchased RxSight securities between November 7, 2024, and July 8, 2025, with a deadline of September 22, 2025, for investors to apply as lead plaintiffs [1]. - Allegations include that RxSight faced "adoption challenges" and structural issues leading to declines in sales and utilization, and that the demand for its products was overstated [2]. Financial Performance - On July 8, 2025, RxSight reported preliminary second-quarter financial results showing significant declines in Light Delivery Device (LDD) sales, LAL utilization, and overall revenue [3]. - The company lowered its full-year 2025 guidance by approximately $42.5 million at the midpoint, attributing the decline to adoption challenges [3]. - Following this announcement, RxSight's stock price fell nearly 38% [3].